Home Cart 0 Sign in  

[ CAS No. 669066-93-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 669066-93-7
Chemical Structure| 669066-93-7
Structure of 669066-93-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 669066-93-7 ]

Related Doc. of [ 669066-93-7 ]

Alternatived Products of [ 669066-93-7 ]

Product Details of [ 669066-93-7 ]

CAS No. :669066-93-7 MDL No. :MFCD14155977
Formula : C6H3BrFNO Boiling Point : -
Linear Structure Formula :- InChI Key :LUJBEFQVVXDCPL-UHFFFAOYSA-N
M.W : 204.00 Pubchem ID :21075870
Synonyms :

Calculated chemistry of [ 669066-93-7 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 37.28
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.28
Log Po/w (XLOGP3) : 1.44
Log Po/w (WLOGP) : 2.22
Log Po/w (MLOGP) : 1.0
Log Po/w (SILICOS-IT) : 2.61
Consensus Log Po/w : 1.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.39
Solubility : 0.831 mg/ml ; 0.00407 mol/l
Class : Soluble
Log S (Ali) : -1.67
Solubility : 4.31 mg/ml ; 0.0212 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.11
Solubility : 0.158 mg/ml ; 0.000776 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.5

Safety of [ 669066-93-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338-P304+P340-P405 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 669066-93-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 669066-93-7 ]
  • Downstream synthetic route of [ 669066-93-7 ]

[ 669066-93-7 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 669066-92-6 ]
  • [ 669066-93-7 ]
YieldReaction ConditionsOperation in experiment
88.7% With lithium aluminium tetrahydride In tetrahydrofuran at -70℃; for 2.25 h; To a solution of 5-bromo-3-fluoro-N-methoxy-N-methylpicolinamide (8.0 g, 30.41 mmol eql) in THE (70 mL), the LAH solution (1M in THF) (15.2 mL, 15.2 mmol, 0.5 eq) was added at -70°C for 15 mm. Reaction was continued at the same temperature for another 2 h. After completion of reaction (monitored by TLC), RM was quenched with sat. Na2SO4 solution and extracted with EtOAc (3x250 mL). The organic layer was washed with water (300 mL), brine (200 mL), dried over Na2SO4, filtered and evaporated under reduced pressure to get the crude. The crude was purified by CC to afford 5-bromo-3-fluoropicolin-aldehyde (5.5 g, 88.70percent) as a brown gum.
Reference: [1] Patent: WO2015/158427, 2015, A1, . Location in patent: Page/Page column 62; 63
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
[3] Patent: WO2005/63690, 2005, A1, . Location in patent: Page/Page column 26
[4] Patent: WO2005/85198, 2005, A2, . Location in patent: Page/Page column 21
[5] Patent: WO2009/36996, 2009, A2, . Location in patent: Page/Page column 106
  • 2
  • [ 886373-28-0 ]
  • [ 669066-93-7 ]
YieldReaction ConditionsOperation in experiment
848 mg
Stage #1: With diisobutylaluminium hydride In dichloromethane; toluene at -78 - 0℃;
Stage #2: With hydrogenchloride In dichloromethane; water; toluene at -78℃;
(1)
Synthesis of 5-bromo-3-fluoropyridine-2-carbaldehyde [172-1] (hereinafter referred to as a compound [172-1])
5-Bromo-3-fluoropyridin-2-carbonitrile obtained by the method described in the document () (4. 5 g) was dissolved in dichloromethane (140 mL) and cooled to -78°C. 1.0M toluene solution (33 mL) of diisobutylaluminum hydride was added at -78°C, and then the reaction mixture was warmed to 0°C and stirred for 5 minutes.
The reaction mixture was cooled again to -78°C, and added 3N-hydrochloric acid, and extracted with chloroform.
The obtained organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure.
The obtained residue was purified by silica gel column chromatography to give the titled compound (848 mg) as a yellow solid.
1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, s), 8.69 (1H, s), 7.80 (1H, dd, J = 9.1, 1.3 Hz).
848 mg With diisobutylaluminium hydride In dichloromethane; toluene at -78 - 0℃; for 0.0833333 h; (1) Synthesis of 5-bromo-3-fluoropyridine-2-carboaldehyde [47-1] (hereinafter referred to as a compound [47-1]) 5-Bromo-3-fluoropyridine-2-carbonitrile (4.5 g), which was obtained by the method described in the document (Journal of Organic Chemistry, 2009, Vol. 74, 4547), was dissolved in dichloromethane (140 mL), and the solution was cooled to -78°C. 1.0M toluene solution of diisobutylaluminum hydride (33 mL) was added to the mixture at -78°C, and the solution was warmed to 0°C and the solution was stirred for 5 minutes. The reaction mixture was cooled again to -78°C, 3N-hydrochloric acid was added to the reaction mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give the titled compound (848 mg) as a yellow solid. 1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, s), 8.69 (1H, s), 7.80 (1H, dd, J = 9.1, 1.3 Hz).
Reference: [1] Patent: EP2669270, 2013, A1, . Location in patent: Paragraph 0950-0951
[2] Patent: EP2878594, 2015, A1, . Location in patent: Paragraph 0582-0584
  • 3
  • [ 669066-90-4 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 4
  • [ 669066-91-5 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 5
  • [ 669066-89-1 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 6
  • [ 15862-37-0 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 7
  • [ 573675-25-9 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 8
  • [ 15862-34-7 ]
  • [ 669066-93-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 13, p. 3608 - 3612
  • 9
  • [ 669066-93-7 ]
  • [ 1150617-54-1 ]
YieldReaction ConditionsOperation in experiment
275 mg With hydrazine hydrate In ethylene glycol at 140℃; for 23 h; To a solution of the compound [172-1] obtained in the process (1) (426 mg) in ethylene glycol (2.1 mL) was added hydrazine monohydrate (197 µL) at room temperature, and then the reaction mixture was stirred at 140°C for 23 hours. After cooling to room temperature, to the reaction mixture was added water, and extracted with a mixed solution of chloroform/isopropanol (volume ratio 10/1). The obtained organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give the titled compound (275 mg) as a yellow solid. 1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, br), 8.65 (1H, d, J = 1.7 Hz), 8.31 (1H, s), 8.04 (1H, s). ESI-MS found: 198 [M+H]+
275 mg With hydrazine hydrate In ethylene glycol at 140℃; for 23 h; (2) Synthesis of 6-bromo-1H-pyrazolo[4,3-b]pyridine [47-2] (hereinafter referred to as a compound [47-2]) To a solution of the compound [47-1] (426 mg) in ethylene glycol (2.1 mL) was added hydrazine monohydrate (197 µL) at room temperature, and the mixture was stirred at 140°C for 23 hours. After cooling to room temperature, water was added to the reaction mixture, and the mixture was extracted with a mixed solution of chloroform/isopropanol (volume ratio 10/1). The obtained organic layer was dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography to give the titled compound (275 mg) as a yellow solid. 1H-NMR (400 MHz, CDCl3) δ: 10.17 (1H, br), 8.65 (1H, d, J = 1.7 Hz), 8.31 (1H, s), 8.04 (1H, s). ESI-MS found: 198 [M + H]+
Reference: [1] Patent: EP2669270, 2013, A1, . Location in patent: Paragraph 0952-0953
[2] Patent: EP2878594, 2015, A1, . Location in patent: Paragraph 0585; 0586
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 669066-93-7 ]

Fluorinated Building Blocks

Chemical Structure| 1162674-74-9

[ 1162674-74-9 ]

5-Bromo-3-fluoro-2-methylpyridine

Similarity: 0.87

Chemical Structure| 31224-43-8

[ 31224-43-8 ]

3-Fluoropicolinaldehyde

Similarity: 0.83

Chemical Structure| 1206968-92-4

[ 1206968-92-4 ]

(5-Bromo-3-fluoropyridin-2-yl)methanol

Similarity: 0.79

Chemical Structure| 886373-28-0

[ 886373-28-0 ]

5-Bromo-3-fluoropicolinonitrile

Similarity: 0.79

Chemical Structure| 831203-14-6

[ 831203-14-6 ]

2-(5-Bromo-3-fluoropyridin-2-yl)acetonitrile

Similarity: 0.78

Bromides

Chemical Structure| 1162674-74-9

[ 1162674-74-9 ]

5-Bromo-3-fluoro-2-methylpyridine

Similarity: 0.87

Chemical Structure| 1206968-92-4

[ 1206968-92-4 ]

(5-Bromo-3-fluoropyridin-2-yl)methanol

Similarity: 0.79

Chemical Structure| 886373-28-0

[ 886373-28-0 ]

5-Bromo-3-fluoropicolinonitrile

Similarity: 0.79

Chemical Structure| 831203-14-6

[ 831203-14-6 ]

2-(5-Bromo-3-fluoropyridin-2-yl)acetonitrile

Similarity: 0.78

Chemical Structure| 31181-90-5

[ 31181-90-5 ]

5-Bromopicolinaldehyde

Similarity: 0.77

Aldehydes

Chemical Structure| 31224-43-8

[ 31224-43-8 ]

3-Fluoropicolinaldehyde

Similarity: 0.83

Chemical Structure| 31181-90-5

[ 31181-90-5 ]

5-Bromopicolinaldehyde

Similarity: 0.77

Chemical Structure| 1227573-02-5

[ 1227573-02-5 ]

3-Bromo-5-fluoroisonicotinaldehyde

Similarity: 0.72

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.71

Chemical Structure| 884494-77-3

[ 884494-77-3 ]

6-Chloro-3-fluoropicolinaldehyde

Similarity: 0.70

Related Parent Nucleus of
[ 669066-93-7 ]

Pyridines

Chemical Structure| 1162674-74-9

[ 1162674-74-9 ]

5-Bromo-3-fluoro-2-methylpyridine

Similarity: 0.87

Chemical Structure| 31224-43-8

[ 31224-43-8 ]

3-Fluoropicolinaldehyde

Similarity: 0.83

Chemical Structure| 1206968-92-4

[ 1206968-92-4 ]

(5-Bromo-3-fluoropyridin-2-yl)methanol

Similarity: 0.79

Chemical Structure| 886373-28-0

[ 886373-28-0 ]

5-Bromo-3-fluoropicolinonitrile

Similarity: 0.79

Chemical Structure| 831203-14-6

[ 831203-14-6 ]

2-(5-Bromo-3-fluoropyridin-2-yl)acetonitrile

Similarity: 0.78